Latest Articles
Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia - The Manila Times
Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia The Manila Times
Published: Dec. 4, 2025, 1:22 p.m.
Absci Announces First Participants Dosed in Phase 1/2a - GlobeNewswire
Absci Announces First Participants Dosed in Phase 1/2a GlobeNewswire
Published: Dec. 4, 2025, 1 p.m.
Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development - The Manila Times
Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development The Manila Times
Published: Dec. 4, 2025, 12:30 p.m.
Revela Raises £411K Pre-Seed to Develop AI Ultrasound Analysis for Endometriosis Diagnosis - Femtech Insider
Revela Raises £411K Pre-Seed to Develop AI Ultrasound Analysis for Endometriosis Diagnosis Femtech Insider
Published: Dec. 4, 2025, 12:14 p.m.
Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development - Laotian Times
Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development Laotian Times
Published: Dec. 4, 2025, 12:08 p.m.
Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development - PR Newswire
Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development PR Newswire
Published: Dec. 4, 2025, 12:08 p.m.
Iridium Appoints Louis Alterman to Board of Directors - bastillepost.com
Iridium Appoints Louis Alterman to Board of Directors bastillepost.com
Published: Dec. 4, 2025, 12:01 p.m.
Lucy Mecklenburgh reveals ‘incredible’ recovery after endometriosis surgery - The News International
Lucy Mecklenburgh reveals ‘incredible’ recovery after endometriosis surgery The News International
Published: Dec. 4, 2025, noon
Bayer Aims To Broaden Mirena’s Use With Phase III Endometrial Hyperplasia Study - Citeline News & Insights
Bayer Aims To Broaden Mirena’s Use With Phase III Endometrial Hyperplasia Study Citeline News & Insights
Published: Dec. 4, 2025, 11:19 a.m.
Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development - acrofan.com
Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development acrofan.com
Published: Dec. 4, 2025, 11:08 a.m.
Link copied to clipboard!